Status:
UNKNOWN
Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous
Lead Sponsor:
Assiut University
Conditions:
Chronic Kidney Disease stage3
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The study aims to explore the ability of Oral activated charcoal to adsorb uremic toxins limiting the progression of chronic kidney disease and delaying the need for hemodialysis in patients with CKD ...
Detailed Description
In recent years, chronic kidney disease(CKD) has become a worldwide public health issue. The main factors affecting the prognosis of patients with chronic kidney disease are its complications, includ...
Eligibility Criteria
Inclusion
- Patients with CKD stages iii and iv
- Patients with age more than 18 years old
Exclusion
- Patients on regular hemodialysis
- Patients with age less than 18 years old
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04311645
Start Date
August 1 2020
End Date
August 1 2021
Last Update
May 14 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.